The soluble tumor necrosis factor receptor etanercept: A new strategy for the treatment of autoimmune rheumatic disease
pág. 281
Adverse effects of new antiepileptic drugs
Filiz Onat, Çigdem Özkara
pág. 325
Solifenacin: Treatment of overactive bladder
pág. 343
Role of dopamine D3 receptors in the addictive properties of ethanol
Christian A. Heidbreder, Michela Andreoli, Clara Marcon, Panayotis K. Thanos, Charles R. Ashby, Jr., Eliot L. Gardner
pág. 355
Omalizumab: An effective anti-IgE treatment for allergic asthma and rhinitis
pág. 367
© 2001-2024 Fundación Dialnet · Todos los derechos reservados